Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-22T22:42:23.068Z Has data issue: false hasContentIssue false
  • English
  • Français

USA300 Methicillin-Resistant Staphylococcus aureus Emerging as a Cause of Bloodstream Infections at Military Medical Centers

Published online by Cambridge University Press:  02 January 2015

Jeffrey Sherwood ,
Matthew Park ,
Paul Robben ,
Timothy Whitman  and
Michael W. Ellis
Jeffrey Sherwood
Affiliation:
Department of Medicine, William Beaumont Army Medical Center, El Paso, Texas Department of Medicine Uniformed Services, University of the Health Sciences, Bethesda, Maryland
Matthew Park
Affiliation:
Department of Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland
Paul Robben
Affiliation:
Department of Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland
Timothy Whitman
Affiliation:
Department of Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland
Michael W. Ellis
Affiliation:
Department of Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland
Get access Rights & Permissions [Opens in a new window]

Abstract

Background.

USA300 methicillin-resistant Staphylococcus aureus (MRSA) is a common cause of skin and soft-tissue infection (SSTI) in military personnel. USA300 MRSA has emerged as an important cause of healthcare-associated bloodstream infection (BSI) in metropolitan centers.

Objective.

To determine the prevalence, risk factors, and patient outcomes associated with USA300 MRSA BSI in military tertiary medical centers.

Design.

Retrospective case-control study.

Patients.

Patients admitted during the period 2001–2009 with MRSA BSI.

Setting.

Walter Reed Army Medical Center (Washington, DC) and National Naval Medical Center (Bethesda, MD) tertiary medical centers with 500 inpatient beds combined, which provide care to active duty service members and military beneficiaries.

Methods.

After identifying patients with MRSA BSI, we collected epidemiological data from electronic medical records and characterized bacterial isolates using pulsed-field gel electrophoresis (PFGE).

Results.

A total of 245 MRSA BSI cases were identified, and 151 isolates were available for analysis. Epidemiological characteristics for the 151 patients with available isolates included the following: mean age, 61 years; male sex, 70%; white race, 62%; and combat-wounded service members, 11%. The crude in-hospital mortality rate was 17%. PFGE demonstrated that 30 (20%) of 151 MRSA BSI cases with isolates available for analysis were due to USA300, and 27 (87%) of these 30 cases were healthcare-associated infection. USA300 was associated with a significantly increasing proportion of MRSA BSI when examined over sequential time periods: 2 (4%) of 51 isolates during 2001–2003, 9 (19%) of 47 isolates during 2004–2006, and 19 (36%) of 53 isolates during 2007–2009 (P<.001).

Conclusion.

USA300 MRSA is emerging as a cause of healthcare-associated BSI in tertiary military medical centers.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 34 , Issue 4 , April 2013 , pp. 393 - 399
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.DeLeo, FR, Otto, M, Kreiswirth, BN, Chambers, HF. Community-associated methicillin-resistant Staphylococcus aureus. Lancet 2010;375(9725):1557–1568.Google Scholar
2.David, MZ, Glikman, D, Crawford, SE, et al.What is community-associated methicillin-resistant Staphylococcus aureus?. J Infect Dis 2008;197(9):1235–1243.Google Scholar
3.David, MZ, Daum, RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010;23(3):616–687.Google Scholar
4.Seybold, U, Kourbatova, EV, Johnson, JG, et al.Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006;42(5):647–656.Google Scholar
5.Popovich, KJ, Weinstein, RA, Hota, B, et al.Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis 2008;46(6):787–794.Google Scholar
6.Chua, T, Moore, CL, Perri, MB, et al.Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit. J Clin Microbiol 2008;46(7):2345–2352.Google Scholar
7.Furuno, JP, Johnson, JK, Schweizer, ML, et al.Community-associated methicillin-resistant Staphylococcus aureus bacteremia and endocarditis among HIV patients: a cohort study. BMC Infectious Diseases 2011;11:298.Google Scholar
8.Ellis, MW, Hospenthal, DR, Dooley, DP, et al.Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004;39(7):971–979.Google Scholar
9.Roberts, SS, Kazragis, RJ. Methicillin-resistant Staphylococcus aureus infections in U.S. service members deployed to Iraq. Mil Med 2009;174(4):408–411.Google Scholar
10.Cohen, AL, Calfee, D, Fridkin, SK, et al.Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC position paper. Infect Control Hosp Epidemiol 2008;29(10):901–913.Google Scholar
11.Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard—sixth edition. Wayne, PA: Clinical and Laboratory Standards Institute, 2003. CLSI document M7-A6.Google Scholar
12.McDougal, LK, Steward, CD, Killgore, GE, et al.Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003;41(11):5113–5120.Google Scholar
13.Landrum, ML, Neumann, C, Cook, C, et al.Epidemiology of Staphylococcus aureus blood and skin and soft tissue infection in the US military health system, 2005–2010. JAMA 2012;308:50–59.Google Scholar
14.Tattevin, P, Schwartz, BS, Graber, CJ, et al.Concurrent epidemics of skin and soft tissue infection and bloodstream infection due to community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2012;55:781–788.Google Scholar
15.Zinderman, CE, Connor, B, Malakooti, MA, et al.Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg Infect Dis 2004;10(5): 941–944.Google Scholar
16.Crum, NF, Lee, RU, Thornton, SA, et al.Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am J Med 2006.119(11):943–951.Google Scholar
17.Morrison-Rodriguez, SM, Pacha, LA, Patrick, JE, Jordan, NN. Community-associated methicillin-resistant Staphylococcus aureus infections at an Army training installation. Epidemiol Infect 2010;138(5):721–729.Google Scholar
18.Huang, XZ, Cash, DM, Chaine, MA, et al.Methicillin-resistant Staphylococcus aureus infection in combat support hospitals in three regions of Iraq. Epidemiol Infect 2011;139:994–997.Google Scholar
19.Johnson, E, Burns, BC, Hayda, RA, Hospenthal, DR, Murray, CK. Infectious complication of open type III tibial fractures among combat casualties. Clin Infect Dis 2007;45:409–415.Google Scholar
20.Murray, CK, Wilkins, K, Molter, NC, et al.Infections complicating the care of combat casualties during operations Iraqi Freedom and Enduring Freedom. J Trauma 2011;71:S62–S73.Google Scholar
21.Lessa, FC, Mu, Y, Ray, SM, et al.Impact of USA300 methicillin-resistant Staphylococcus aureus on clinical outcomes of patients with pneumonia or central line-associated bloodstream infections. Clin Infect Dis 2012;55:232–241.Google Scholar
22.Cosgrove, SE, Sakoulas, G, Perencevich, EN, et al.Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36(1):53–59.CrossRefGoogle ScholarPubMed
23.Liu, C, Graber, CJ, Karr, M, et al.A population based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004–2005. Clin Infect Dis 2008;46(11):1637–1646.Google Scholar
24.Moran, GJ, Krishnadasan, A, Gorwitz, RJ, et al.Methicillin-resistant Staphylococcus aureus infections among patients in the emergency department. N Engl J Med 2006;355:666–674.Google Scholar
25.Huang, H, Flynn, NM, King, JH, Monchaud, C, Morita, M, Cohen, SH. Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California. J Clin Microbiol 2006;44:2423–2437.Google Scholar
26.Popovich, KJ, Weinstein, RA, Aroutcheva, A, Rice, T, Hota, B. Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics. Clin Infect Dis 2010;50:979–987.Google Scholar
27.Jenkins, TC, McCollister, BD, Sharma, R, et al.Epidemiology of healthcare-associated bloodstream infection caused by USA300 strains of methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Infect Control Hosp Epidemiol 2009;30:233–241.Google Scholar